AstraZeneca
Senior Analyst, Forecasting Early Assets at AstraZeneca sits within the Global Business Service (Finance) team and is responsible for developing short- and long-term brand forecasts (revenue, volume and patients) for strategic brands and early assets. The role focuses on patient-based forecast models for Global (Top 8 markets) or US, collaborating closely with Forecast Leaders and commercial partners to inform brand strategy and planning. It supports continuous improvement of forecasting capabilities and integrates market and research insights into forecast assumptions.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Senior Analyst - Forecasting
American Association of Physicists in Medicine
Associate Director/Lead, US Solid Tumor Forecasting, Global Oncology
Takeda Pharmaceutical Company Limited
Senior Manager of Global Forecasting, Obesity
Amgen
Director, Global Forecasting
Revolution Medicines
CD&A - Senior Manager, US Forecasting
Amgen
Senior Manager - Commercial Forecasting
Amgen